Chemed Corp. (NYSE:CHE) CEO Kevin J. Mcnamara sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, October 31st. The shares were sold at an average price of $223.42, for a total value of $2,234,200.00. Following the completion of the transaction, the chief executive officer now directly owns 170,016 shares in the company, valued at $37,984,974.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Chemed Corp. (NYSE:CHE) last issued its quarterly earnings data on Thursday, October 26th. The company reported $2.15 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.00 by $0.15. The firm had revenue of $417.40 million during the quarter, compared to analysts’ expectations of $414.34 million. Chemed Corp. had a net margin of 4.62% and a return on equity of 27.69%. Chemed Corp.’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the prior year, the company posted $1.73 earnings per share.

TRADEMARK VIOLATION NOTICE: “Kevin J. Mcnamara Sells 10,000 Shares of Chemed Corp. (CHE) Stock” was posted by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be read at https://www.watchlistnews.com/kevin-j-mcnamara-sells-10000-shares-of-chemed-corp-che-stock/1674706.html.

A number of large investors have recently modified their holdings of the stock. Kalos Management Inc. boosted its holdings in Chemed Corp. by 0.7% in the second quarter. Kalos Management Inc. now owns 6,521 shares of the company’s stock worth $1,333,000 after purchasing an additional 45 shares in the last quarter. Capstone Asset Management Co. boosted its holdings in Chemed Corp. by 2.7% during the second quarter. Capstone Asset Management Co. now owns 1,857 shares of the company’s stock valued at $380,000 after acquiring an additional 49 shares during the period. Nisa Investment Advisors LLC boosted its holdings in Chemed Corp. by 0.4% during the second quarter. Nisa Investment Advisors LLC now owns 11,600 shares of the company’s stock valued at $2,373,000 after acquiring an additional 50 shares during the period. Amalgamated Bank boosted its holdings in Chemed Corp. by 2.9% during the second quarter. Amalgamated Bank now owns 2,203 shares of the company’s stock valued at $451,000 after acquiring an additional 62 shares during the period. Finally, State Board of Administration of Florida Retirement System boosted its holdings in Chemed Corp. by 0.7% during the second quarter. State Board of Administration of Florida Retirement System now owns 8,681 shares of the company’s stock valued at $1,776,000 after acquiring an additional 64 shares during the period. Hedge funds and other institutional investors own 97.24% of the company’s stock.

Several research firms have commented on CHE. Zacks Investment Research raised Chemed Corp. from a “hold” rating to a “buy” rating and set a $251.00 price objective on the stock in a research report on Thursday. TheStreet raised Chemed Corp. from a “c+” rating to an “a-” rating in a research report on Friday, October 27th. Royal Bank Of Canada raised their price objective on Chemed Corp. to $232.00 and gave the company a “sector perform” rating in a research report on Tuesday. KeyCorp reissued a “hold” rating on shares of Chemed Corp. in a research report on Friday, October 27th. Finally, Oppenheimer Holdings, Inc. raised their price objective on Chemed Corp. from $220.00 to $225.00 and gave the company an “outperform” rating in a research report on Friday, October 27th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $236.00.

About Chemed Corp.

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Insider Buying and Selling by Quarter for Chemed Corp. (NYSE:CHE)

Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.